Mer receptor tyrosine kinase is a therapeutic target in pre–B-cell acute lymphoblastic leukemia

por Linger, Rachel M. A., Lee-Sherick, Alisa B., DeRyckere, Deborah, Cohen, Rebecca A., Jacobsen, Kristen M., McGranahan, Amy, Brandão, Luis N., Winges, Amanda, Sawczyn, Kelly K., Liang, Xiayuan, Keating, Amy K., Tan, Aik Choon, Earp, H. Shelton, Graham, Douglas K.
Publicado 2013

MERTK receptor tyrosine kinase is a therapeutic target in melanoma

por Schlegel, Jennifer, Sambade, Maria J., Sather, Susan, Moschos, Stergios J., Tan, Aik-Choon, Winges, Amanda, DeRyckere, Deborah, Carson, Craig C., Trembath, Dimitri G., Tentler, John J., Eckhardt, S. Gail, Kuan, Pei-Fen, Hamilton, Ronald L., Duncan, Lyn M., Miller, C. Ryan, Nikolaishvili-Feinberg, Nana, Midkiff, Bentley R., Liu, Jing, Zhang, Weihe, Yang, Chao, Wang, Xiaodong, Frye, Stephen V., Earp, H. Shelton, Shields, Janiel M., Graham, Douglas K.
Publicado 2013